

<!DOCTYPE html>
<!--[if IE 8]><html class="ie ie8"><![endif]-->
<!--[if IE 9]><html class="ie ie9"><![endif]-->
<!--[!(IE)]><!-->
<html xmlns="http://www.w3.org/1999/xhtml">
<!--<![endif]-->
<head id="Head1"><title>
	Legal Notice | IMBRUVICA&#174; (ibrutinib)
</title>
    <script type="text/javascript">
        //var link = document.createElement('link');
        //link.rel = 'preload'; link.id = 'id1'; link.rel = 'stylesheet'; link.href = '/css/Imbruvica2/bundle.min.css?v=' + Date.now();
        //document.head.appendChild(link);
    </script>
    <link rel="shortcut icon" type="image/ico" href="images/imbruvica2/favicon.ico" /><meta name="viewport" content="user-scalable=no, initial-scale=1, maximum-scale=1, minimum-scale=1, width=device-width" /><meta charset="utf-8" /><meta http-equiv="X-UA-Compatible" content="IE=edge" /><meta name="format-detection" content="telephone=no" />

<!-- Google Tag Manager -->
<script>
    (function (w, d, s, l, i) {
        w[l] = w[l] || [];
        w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' });
        var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : '';
        j.async = true;
        j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
    })
    (window, document, 'script', 'dataLayer', 'GTM-T3CBKP');
</script>

<!-- End Google Tag Manager -->

    <script src="scripts/Imbruvica2/libraries.min.js"></script>
    <link rel="stylesheet" type="text/css" href="https://cloud.typography.com/7350074/635908/css/fonts.css" />
    <style type="text/css">
        @font-face{
            font-family:"HelveticaNeueW02-57Cn";
            src:url("Fonts/Imbruvica2/694054/abf5b6e2-74e5-446b-b924-22c9749b33b6.eot%3F");
            src:url("Fonts/Imbruvica2/694054/abf5b6e2-74e5-446b-b924-22c9749b33b6.eot%3F") format("eot"),url("Fonts/Imbruvica2/694054/21f9012d-b72a-422e-84c3-96619ee09ae4.woff2") format("woff2"),url("Fonts/Imbruvica2/694054/c6206d3d-1ef8-44ad-96fa-c25e22252eb0.woff") format("woff"),url("Fonts/Imbruvica2/694054/6fddd219-58f2-42d3-99d5-5abbfcfde1a1.ttf") format("truetype"),url("Fonts/Imbruvica2/694054/f620604b-846b-4517-95c0-aa8a60dbb16c.svg") format("svg");
        }   
        @font-face{
            font-family:"HelveticaNeueW02-77BdCn_694066";
            src:url("Fonts/Imbruvica2/694066/77cb0adc-646b-4830-8f4c-3db7adbb8dc4.eot%3F");
            src:url("Fonts/Imbruvica2/694066/77cb0adc-646b-4830-8f4c-3db7adbb8dc4.eot%3F") format("eot"),url("Fonts/Imbruvica2/694066/d250f8f6-d2cb-4a70-971b-c9760008998c.woff2") format("woff2"),url("Fonts/Imbruvica2/694066/631bf655-ced5-4627-93d4-89d1bdfe3014.woff") format("woff"),url("Fonts/Imbruvica2/694066/96740819-d387-437f-b739-9778ddc5e5b9.ttf") format("truetype"),url("Fonts/Imbruvica2/694066/05729794-671d-4a73-a294-f2f447795319.svg") format("svg");
        }
    </style>
    <script type="text/javascript">
        var MTUserId = '24758d2e-f283-4796-a1e8-775bcaea302c';
        var MTFontIds = new Array();

        MTFontIds.push("694054"); // Neue Helvetica® W02 57 Condensed 
        MTFontIds.push("694066"); // Neue Helvetica® W02 77 Condensed Bold 
        (function () {
            var mtTracking = document.createElement('script');
            mtTracking.type = 'text/javascript';
            mtTracking.async = 'true';
            mtTracking.src = '/scripts/Imbruvica2/mtiFontTrackingCode.js';

            (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(mtTracking);
        })();
    </script> 
    <link rel="stylesheet" href="css/Imbruvica2/bundle.min.css" /><meta name="Generator" content="Sitefinity 10.2.6602.0 PU" /><link rel="canonical" href="legal.html" /><link href="Telerik.Web.UI.WebResource.axd%3Fd=PMrIT5dOWaVYIcpFWUE4nGVDAjhiVC9rE7UCcfrvqAUVEF94EoWSKTHfoveEBS4nqI93uk7-gLASUXXwO_KDUkyF7r6jeNsmsH_RVvPRutSNeEGjDdJTZ8KCZLLg1S5r0&amp;t=635307339853130836&amp;compress=0&amp;_TSM_CombinedScripts_=%3B.css" type="text/css" rel="stylesheet" /><link href="app_themes/imbruvica2/global/styles.css%3Fv=636820116100000000.css" type="text/css" rel="stylesheet" /><meta name="description" content="Find legal information for IMBRUVICA®. See full prescribing &amp; safety info. " /></head>
<body id="bodyTag" class="home">
    

<!-- Google Tag Manager (noscript) -->
<noscript>
    <iframe src="https://www.googletagmanager.com/ns.html?id="GTM-T3CBKP" height="0" width="0" style="display: none; visibility: hidden"></iframe>
</noscript>

<!-- End Google Tag Manager (noscript) -->

    <!--[if lt IE 10]>
    <p class="browsehappy">You are using an <strong>outdated</strong> browser. Please <a href="http://browsehappy.com/">upgrade your browser</a> to improve your experience.</p>
    <![endif]-->
    <form method="post" action="legal.html" id="form1">
<input type="hidden" name="ctl08_TSM" id="ctl08_TSM" value="" />
<input type="hidden" name="ctl09_TSSM" id="ctl09_TSSM" value="" />
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="Yo0LSssDIaJ5NMgczChZxVwMu4W4wWOLi2KaSu/3F+KLm/5l7KpoWrJZIf5Vo/38u01ijQdKZihOh9UjRNg5UBVYnfABmH6HisvpNu3X3rs=" />


<script type="text/javascript">
//<![CDATA[
var __cultureInfo = {"name":"en","numberFormat":{"CurrencyDecimalDigits":2,"CurrencyDecimalSeparator":".","IsReadOnly":true,"CurrencyGroupSizes":[3],"NumberGroupSizes":[3],"PercentGroupSizes":[3],"CurrencyGroupSeparator":",","CurrencySymbol":"$","NaNSymbol":"NaN","CurrencyNegativePattern":0,"NumberNegativePattern":1,"PercentPositivePattern":0,"PercentNegativePattern":0,"NegativeInfinitySymbol":"-Infinity","NegativeSign":"-","NumberDecimalDigits":2,"NumberDecimalSeparator":".","NumberGroupSeparator":",","CurrencyPositivePattern":0,"PositiveInfinitySymbol":"Infinity","PositiveSign":"+","PercentDecimalDigits":2,"PercentDecimalSeparator":".","PercentGroupSeparator":",","PercentSymbol":"%","PerMilleSymbol":"‰","NativeDigits":["0","1","2","3","4","5","6","7","8","9"],"DigitSubstitution":1},"dateTimeFormat":{"AMDesignator":"AM","Calendar":{"MinSupportedDateTime":"\/Date(-62135596800000)\/","MaxSupportedDateTime":"\/Date(253402300799999)\/","AlgorithmType":1,"CalendarType":1,"Eras":[1],"TwoDigitYearMax":2029,"IsReadOnly":true},"DateSeparator":"/","FirstDayOfWeek":0,"CalendarWeekRule":0,"FullDateTimePattern":"dddd, MMMM d, yyyy h:mm:ss tt","LongDatePattern":"dddd, MMMM d, yyyy","LongTimePattern":"h:mm:ss tt","MonthDayPattern":"MMMM d","PMDesignator":"PM","RFC1123Pattern":"ddd, dd MMM yyyy HH\u0027:\u0027mm\u0027:\u0027ss \u0027GMT\u0027","ShortDatePattern":"M/d/yyyy","ShortTimePattern":"h:mm tt","SortableDateTimePattern":"yyyy\u0027-\u0027MM\u0027-\u0027dd\u0027T\u0027HH\u0027:\u0027mm\u0027:\u0027ss","TimeSeparator":":","UniversalSortableDateTimePattern":"yyyy\u0027-\u0027MM\u0027-\u0027dd HH\u0027:\u0027mm\u0027:\u0027ss\u0027Z\u0027","YearMonthPattern":"MMMM yyyy","AbbreviatedDayNames":["Sun","Mon","Tue","Wed","Thu","Fri","Sat"],"ShortestDayNames":["Su","Mo","Tu","We","Th","Fr","Sa"],"DayNames":["Sunday","Monday","Tuesday","Wednesday","Thursday","Friday","Saturday"],"AbbreviatedMonthNames":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec",""],"MonthNames":["January","February","March","April","May","June","July","August","September","October","November","December",""],"IsReadOnly":true,"NativeCalendarName":"Gregorian Calendar","AbbreviatedMonthGenitiveNames":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec",""],"MonthGenitiveNames":["January","February","March","April","May","June","July","August","September","October","November","December",""]},"eras":[1,"A.D.",null,0]};//]]>
</script>

<script src="./Telerik.Web.UI.WebResource.axd%3F_TSM_HiddenField_=ctl08_TSM&amp;compress=0&amp;_TSM_CombinedScripts_=%3B%3BSystem.Web.Extensions,+Version=4.0.0.0,+Culture=neutral,+PublicKeyToken=31bf3856ad364e35:en:4ae4914f-8c8e-4123-9d05-414d87b4" type="text/javascript"></script>
<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="B8F552DD" /><input type="hidden" name="ctl00$ctl08" id="ctl08" />
<script type="text/javascript">
//<![CDATA[
Sys.Application.setServerId("ctl08", "ctl00$ctl08");
Sys.Application._enableHistoryInScriptManager();
//]]>
</script>

        <!--Desktop main navigation-->
        <header class="row show-for-medium-up">
            <div class="large-12 columns">
                <div class="main-header">
                    <div class="row main-nav small-collapse">
                        <div class="large-3 columns">
                            <div class="logo-holder rounded-bottom">
                                <figure>
                                    <a href="index.html" class="logo">
                                        <img src="images/Imbruvica2/logo-imbruvica.png"></a>
                                </figure>
                            </div>
                        </div>
                        <div class="large-6 columns">
                            <div class="top-nav">
                                



<div style="width: 80%;margin: 0 auto;">
  <ul>
    <li><a href="index.html">Home</a></li>
    <li><a href="legal.html#" class="openFloatingIsi">Important Side Effect Information</a></li>
    <li><a href="https://www.imbruvica.com/prescribing-information" target="_blank">Prescribing Information</a></li>
  </ul>
</div>

                            </div>
                        </div>
                        <div class="large-3 columns">
                            <a href="https://www.imbruvicahcp.com" class="button-1 show-lso" target="_blank" data-lso-type="0">For Healthcare Professionals</a>
                            

<div class="btn-dropdown opened">
    <p>
        <img src="images/Imbruvica2/yi-btn-text.png" />
    </p>
    <div class="hoverContent">
        <p>From IMBRUVICA&reg; access and affordability support options
            <br />
            to nurse call support&mdash;
            <br />
            we're here to help.</p>
        <a href="patient-support/access-support/enrollment-form.html" class="button-1">Enroll Now</a>
        <a class="learnmore_link" href="https://www.imbruvica.com/you-i-support">Or learn more about the program</a>
    </div>
</div>
                            
                        </div>
                    </div>
                </div>
            </div>
        </header>
        <!--Mobile main navigation-->
        <header class="main-header show-for-small mob-header">
            <div class="row hambBlock">
                <div class="small-7 columns">
                    <div class="logo-holder rounded-bottom">
                        <figure>
                            <a href="index.html" class="logo">
                                <img src="images/Imbruvica2/logo-imbruvica.png"></a>
                        </figure>
                    </div>
                </div>
                <div class="small-5 columns">
                    <div class="hamburger right">
                        <span class="divider"></span>
                        <span class="divider"></span>
                        <span class="divider"></span>
                        <span>Menu</span>
                    </div>
                </div>
            </div>
        </header>
        <div class="row top-nav show-for-small">
            




<div class="small-6 columns">
  <div class="v-align">
    <a href="legal.html#" class="openFloatingIsi">Important Side Effect Information</a>
  </div>
</div>
<div class="small-6 columns">
  <div class="v-align">
    <a href="https://www.imbruvica.com/prescribing-information" target="_blank">Prescribing Information</a>
  </div>
  <!--i class="search-mobile"></i-->
</div>
        </div>
        <div class="mob-menu-block show-for-small">
            <div class="row">
                <div class="small-12">
                    <div class="close-menu">
                        <span></span>
                    </div>
                </div>
            </div>
            <nav class="mob-menu">
                


<ul class="item-list">
    <li>
        <ul class="item-sub-menu">
            <li class="cll-item"><a href="https://www.imbruvica.com/cll" class="active"><span class="indication-text">CLL</span> <span class="gray-text">Chronic Lymphocytic Leukemia</span></a></li>
            <li class="mcl-item"><a href="https://www.imbruvica.com/mcl"><span class="indication-text">MCL</span> <span class="gray-text">Previously Treated Mantle Cell Lymphoma</span></a></li>
            <li class="wm-item"><a href="https://www.imbruvica.com/wm"><span class="indication-text">WM</span> <span class="gray-text">Waldenstr&ouml;m's Macroblobulinemia</span></a></li>
            <li class="mzl-item"><a href="https://www.imbruvica.com/mzl"><span class="indication-text">MZL</span> <span class="gray-text">Previously Treated Marginal Zone Lymphoma</span></a></li>
            <li class="cgvhd-item"><a href="https://www.imbruvica.com/cgvhd"><span class="indication-text">cGVHD</span> <span class="gray-text">Previously Treated Chronic Graft Versus Host Disease</span></a></li>
        </ul>
    </li>
    <li>
        <a href="http://www.imbruvicahcp.com" target="_blank" class="show-lso" data-lso-type="1">For Healthcare Professionals</a>
    </li>
    <li>
        <a href="https://www.imbruvica.com/you-i-support">YOU&amp;i&trade; Support Program</a>
    </li>
    <li>
        <a href="legal.html#" class="openFloatingIsi">Important Side Effect Information</a>
    </li>
    <!--<li>
        <a href="http://www.pharmacyclicsmedinfo.com">Medical Information</a>
    </li>-->
    <li>
        <a href="https://www.imbruvica.com/prescribing-information">Prescribing Information</a>
    </li>
</ul>

            </nav>
        </div>

        <div class="marquee">
            
<div class='sfContentBlock'><img src="sf-images/librariesprovider7/page-banners/legal_terms.jpg%3Fsfvrsn=c5a8c914_0" data-displaymode="Original" alt="Legal Notice IMBRUVICA® (ibrutinib)" title="Legal Notice IMBRUVICA® (ibrutinib)" class="show-for-medium-up">
<img src="sf-images/librariesprovider7/mobile-banners/mob-legal@2x.jpg%3Fsfvrsn=28cdf514_2" data-displaymode="Original" alt="Legal Notice IMBRUVICA® (ibrutinib)" title="Legal Notice IMBRUVICA® (ibrutinib)" class="hide-for-medium-up">


</div>
        </div>

        <div id="divMainContent" class="home main">
            
<div class="indication-bg">
 <div class="row small-collapse">
     <div class="large-10 columns large-offset-1">
         <div class="slick-target show-for-medium-up">
     <a href="https://www.imbruvica.com/cll">
         <div class="indication-section slick-slide cll">
             <span class="ind-abbreviation">CLL</span>
             <span class="ind-full">Chronic Lymphocytic <br />Leukemia</span>
         </div>
     </a>
     <a href="https://www.imbruvica.com/mcl">
         <div class="indication-section slick-slide mcl">
             <span class="ind-abbreviation">MCL</span>
             <span class="ind-full">Previously Treated <br />Mantle Cell Lymphoma</span>
         </div>
     </a>
     <a href="https://www.imbruvica.com/wm">
         <div class="indication-section slick-slide wm">
             <span class="ind-abbreviation">WM</span>
             <span class="ind-full">Waldenstr&#246;m&#39;s <br />Macroglobulinemia</span>
         </div>
     </a>
     <a href="https://www.imbruvica.com/mzl">
         <div class="indication-section slick-slide mzl">
             <span class="ind-abbreviation">MZL</span>
             <span class="ind-full">Previously&nbsp;Treated<br />Marginal&nbsp;Zone Lymphoma</span>
         </div>
     </a>
     <a href="https://www.imbruvica.com/cgvhd">
         <div class="indication-section slick-slide cgvhd">
             <span class="ind-abbreviation">cGVHD</span>
             <span class="ind-full">Previously Treated Chronic<br />Graft Versus Host Disease</span>
         </div>
     </a>
          </div>
<div class="mobile-nav hide-for-medium-up">
     <a href="https://www.imbruvica.com/cll">
         <div class="indication-section slick-slide cll">
             <span class="ind-abbreviation">CLL</span>
             <span class="ind-full">Chronic Lymphocytic <br />Leukemia</span>
         </div>
     </a>
     <a href="https://www.imbruvica.com/mcl">
         <div class="indication-section slick-slide mcl">
             <span class="ind-abbreviation">MCL</span>
             <span class="ind-full">Previously Treated <br />Mantle Cell Lymphoma</span>
         </div>
     </a>
     <a href="https://www.imbruvica.com/wm">
         <div class="indication-section slick-slide wm">
             <span class="ind-abbreviation">WM</span>
             <span class="ind-full">Waldenstr&#246;m&#39;s <br />Macroglobulinemia</span>
         </div>
     </a>
     <a href="https://www.imbruvica.com/mzl">
         <div class="indication-section slick-slide mzl">
             <span class="ind-abbreviation">MZL</span>
             <span class="ind-full">Previously&nbsp;Treated<br />Marginal&nbsp;Zone Lymphoma</span>
         </div>
     </a>
     <a href="https://www.imbruvica.com/cgvhd">
         <div class="indication-section slick-slide cgvhd">
             <span class="ind-abbreviation">cGVHD</span>
             <span class="ind-full">Previously Treated Chronic<br />Graft Versus Host Disease</span>
         </div>
     </a>
          </div>
     </div>
 </div>
</div>


            <div class="row content">
                
<div class='sfContentBlock'><div class="mainBlock">
<h2 style="color:#007dac;">Legal Terms of Use</h2>
<p>Pharmacyclics LLC. ("Pharmacyclics") owns and operates this website, which is protected by worldwide copyright laws. Pharmacyclics authorizes you to copy documents or pages published by Pharmacyclics on this website for your noncommercial reference use only, provided any copy you make retains all copyright or other proprietary notices and any disclaimer contained thereon. No modification or further reproduction of the content is permitted. The sender of any communications to this website or otherwise to the owners of the site are responsible for the content and information contained therein, including its truthfulness and accuracy.<br>
<br>
This website provides selected information available about a range of disease topics. The information is not intended to be a substitute for the advice of a healthcare professional, or a recommendation for any particular treatment plan. Medical information changes rapidly, and it is important that consumers rely on the advice of a healthcare professional to employ good clinical judgment for the specific conditions of individual patients.<br>
<br>
Pharmacyclics, and the logo are registered trademarks of Pharmacyclics. The use or misuse of these trademarks or any other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, publication rights, and communications regulations and statutes. Please be aware that Pharmacyclics actively and aggressively enforces its intellectual property rights to the fullest extent permitted by law.<br>
<br>
While Pharmacyclics intends to periodically update this website, it makes no representations or warranties as to its accuracy or completeness. Access to and use of the content is solely at your own risk, and neither Pharmacyclics nor any party involved in creating or delivering this site shall be liable for any damage of any kind arising out of the access, use, or inability to access or use this site, or for any omissions or errors. Pharmacyclics reserves the right to alter or delete material from this site at any time.<br>
<br>
Certain links on this site lead to resources located on servers maintained by others over whom Pharmacyclics has no control. We provide links to these external sites for your convenience. Pharmacyclics neither endorses nor makes any representation as to the accuracy or any other aspect of the information contained on such servers. Should any visitor to this website provide information such as questions, comments, suggestions, ideas, or the like through the feedback mechanisms located in the site, Pharmacyclics shall have no obligation of any kind with respect to such information and shall be free to destroy, reproduce, use, disclose, and distribute the information to others without limitation.<br>
<br>
This website may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements, including our expected liquidity position and timing of the receipt of certain milestone payments, and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used on this Web site, the words "anticipate", "believe", "estimate", "expect", "expectation", "goal", "should", "would", "project", "plan", "predict", "intend", "target" and similar expressions are intended to identify such forward-looking statements.<br>
<br>
These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, expected liquidity or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing governmental regulation, our ability to commercialize, manufacture and achieve market acceptance of any of our product candidates, for which we rely heavily on collaboration with third parties, and our ability to protect and enforce our intellectual property rights and to operate without infringing upon the proprietary rights of third parties. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements and no assurance can be given that the actual results will be consistent with these forward-looking statements.<br>
<br>
For more information about the risks and uncertainties that may affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Commission, including our transition report on Form 10-K for the six-month period ended December 31, 2012 and quarterly reports on Form 10-Q. We do not intend to update any of the forward-looking statements after their release on our Web site to conform these statements to actual results, to changes in management's expectations or otherwise, except as may be required by law.<br>
<br>
© 2018 Pharmacyclics - All Rights Reserved.</p>
<div></div>
</div>
<p>&nbsp;</p>


</div>
            </div>
        </div>

        <section id="lso">
            <div class="lso-container">
                <div class="lso-content">
                    
<div class='sfContentBlock'><div class="close-lso">&nbsp;</div>
<h2>You are now leaving www.imbruvica.com</h2>
<p>By clicking "OK" below you will be taken to a website that may contain links or references to other websites to which our <a href="http://www.pharmacyclics.com/privacy-policy" target="_blank" class="leaving-imb">Privacy Policy</a> may not apply. We encourage you to read the Privacy Policy of every website you visit.</p>
<p>For any questions about the Pharmacyclics Privacy Policy, please visit <a href="http://www.pharmacyclics.com/privacy-policy" target="_blank" class="leaving-imp-pcyc">www.pharmacyclics.com</a>.</p>
<div class="btn-container">
<div class="button-1 leaving-imb-ok" data-action="leave">OK</div>
<div class="button-5 leaving-imb-cancel" data-action="cancel">Cancel</div>
</div>


</div>
                </div>
            </div>
        </section>
        <section id="lso-healthcare">
            <div class="lso-container">
                <div class="lso-content">
                    
<div class='sfContentBlock'><div class="close-lso">&nbsp;</div>
<h2>Are you a healthcare professional?</h2>
<p>You are leaving the patient and caregiver site and entering the US Healthcare professional site. The information contained in this site is intended for US healthcare professionals only. Click &ldquo;OK&rdquo; below if you are a healthcare professional.</p>
<div class="btn-container">
<div class="button-1 leaving-ibm-hcp-ok" data-action="leave">OK</div>
<div class="button-5 leaving-ibm-hcp-cancel" data-action="cancel">Cancel</div>
</div>


</div>
                </div>
            </div>
        </section>
        <footer class="interior-footer">
            

        </footer>
        <article id="floatingIsi">
            <img src="images/Imbruvica2/_temp/guide-isi-copy.png" class="guide" />
            <div class="toggle">+</div>
            <div class="wrapper"></div>
        </article>
        <div class="isi-bg">
            <article id="isi">
                <img src="images/Imbruvica2/_temp/guide-isi-copy.png" class="guide" />
                <div class="row">
                    <div class="large-7 columns">
                        
<div class='sfContentBlock'><p class="title"><span style="color: #00aeef;">IMPORTANT SIDE EFFECT INFORMATION</span></p>
<p class="breakpoint"><span style="color: #000000;"><strong>Before taking IMBRUVICA<sup>&reg;</sup></strong></span><strong>, tell your healthcare provider about all of your medical conditions, including if you:</strong></p>
<ul>
    <li><span style="color: #000000;">have had recent surgery or plan to have surgery. Your healthcare provider may stop IMBRUVICA<sup>&reg;</sup> for any planned medical, surgical, or dental procedure</span></li>
    <li><span style="color: #000000;">have bleeding problems</span></li>
    <li><span style="color: #000000;">have or had heart rhythm problems, smoke, or have a medical condition that increases your risk of heart disease, such as high blood pressure, high cholesterol, or diabetes</span></li>
    <li><span style="color: #000000;">have an infection</span></li>
    <li><span style="color: #000000;">have liver problems</span></li>
    <li><span style="margin-bottom: 0.53em; color: #000000;">are pregnant or plan to become pregnant. IMBRUVICA<sup>&reg;</sup> can harm your unborn baby. If you are able to become pregnant, your healthcare provider will do a pregnancy test before starting treatment with IMBRUVICA<sup>&reg;</sup>
    </span>
    <ul>
        <li><span style="color: #000000;"><strong>Females</strong> should not become pregnant during treatment and for 1 month after the last dose of IMBRUVICA<sup>&reg;</sup>
        </span></li>
        <li><span style="color: #000000;"><strong>Males </strong>should avoid getting female partners pregnant during treatment and for 1 month after the last dose of IMBRUVICA<sup>&reg;</sup></span></li>
    </ul>
    </li>
    <li><span style="color: #000000;">are breastfeeding or plan to breastfeed. You and your healthcare provider should decide if you will take IMBRUVICA<sup>&reg;</sup> or breastfeed</span></li>
</ul>
<p class="sm-margin-bottom"><span style="color: #000000;"><strong>Tell your healthcare provider about all the medicines you take,</strong> including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking IMBRUVICA<sup>&reg;</sup> with certain other medicines may affect how IMBRUVICA<sup>&reg;</sup> works and can cause side effects.</span></p>
<p class="title"><strong><span style="color: #00aeef;">How should I take IMBRUVICA<sup>&reg;</sup>?</span></strong></p>
<ul>
    <li><span style="color: #000000;">Take IMBRUVICA<sup>&reg;</sup> exactly as your healthcare provider tells you to take it</span></li>
    <li><span style="color: #000000;">Take IMBRUVICA<sup>&reg;</sup> 1 time a day</span></li>
    <li><span style="color: #000000;">Swallow IMBRUVICA<sup>&reg;</sup> capsules and tablets whole with a glass of water</span></li>
    <li><span style="color: #000000;"></span><span style="color: #000000;">Do not open, break, or chew IMBRUVICA<sup>&reg;</sup> capsules</span></li>
    <li><span style="color: #000000;">Do not cut, crush, or chew IMBRUVICA<sup>&reg;</sup> tablets</span></li>
    <li><span style="color: #000000;">Take IMBRUVICA<sup>&reg;</sup> at about the same time each day</span></li>
    <li><span style="color: #000000;">If you miss a dose of IMBRUVICA<sup>&reg;</sup> take it as soon as you remember on the same day. Take your next dose of IMBRUVICA<sup>&reg;</sup> at your regular time on the next day. Do not take extra doses of IMBRUVICA<sup>&reg;</sup> to make up for a missed dose</span></li>
    <li><span style="color: #000000;">If you take too much IMBRUVICA<sup>&reg;</sup>, call your healthcare provider or go to the nearest hospital emergency room right away</span></li>
</ul>
<p class="title"><strong><span style="color: #00aeef;">What should I avoid while taking IMBRUVICA<sup>&reg;</sup>?</span></strong></p>
<ul>
    <li><span style="color: #000000;">You should not drink grapefruit juice, eat grapefruit, or eat Seville oranges (often used in marmalades) during treatment with IMBRUVICA<sup>&reg;</sup>. These products may increase the amount of IMBRUVICA<sup>&reg;</sup> in your blood</span></li>
</ul>
<p class="sm-margin-bottom title"><strong><span style="color: #00aeef;">What are the possible side effects of IMBRUVICA<sup>&reg;</sup>?</span></strong></p>
<p class="sm-margin-bottom"><strong><span style="color: #000000;">IMBRUVICA<sup>&reg;</sup> may cause serious side effects, including:</span></strong></p>
<ul>
    <li><span style="color: #000000;"><strong>Bleeding problems&nbsp;(hemorrhage)</strong> are common during treatment with IMBRUVICA<sup>&reg;</sup>&nbsp;and can also be serious and may lead to death. Your risk of bleeding may increase if you are also taking a blood thinner medicine. Tell your healthcare provider if you have any signs of bleeding, including: blood in your stools or black stools (looks like tar), pink or brown urine, unexpected bleeding or bleeding that is severe or that you cannot control, vomit blood or vomit looks like coffee grounds, cough up blood or blood clots, increased bruising, dizziness, weakness, confusion, change in your speech, or a headache that lasts a long time </span></li>
    <li><span style="color: #000000;"><strong>Infections</strong> can happen during treatment with IMBRUVICA<sup>&reg;</sup>. These infections can be serious and may lead to death. Tell your healthcare provider right away if you have fever, chills, weakness, confusion, or other signs or symptoms of an infection during treatment with IMBRUVICA<sup>&reg;</sup></span></li>
    <li><span style="color: #000000;"><strong>Decrease in blood cell counts.</strong> Decreased blood counts (white blood cells, platelets, and red blood cells) are common with IMBRUVICA<sup>&reg;</sup>, but can also be severe. Your healthcare provider should do monthly blood tests to check your blood counts</span></li>
    <li><span style="color: #000000;"><strong>Heart rhythm problems (ventricular arrhythmias,&nbsp;atrial fibrillation and atrial flutter).</strong>&nbsp;Serious heart rhythm problems and death have happened in people treated with IMBRUVICA<sup>&reg;</sup>, especially in people who have an increased risk for heart disease, have an infection, or who have had heart rhythm problems in the past. Tell your healthcare provider if you get any symptoms of heart rhythm problems, such as feeling as if your heart is beating fast and irregular, lightheadedness, dizziness, shortness of breath, chest discomfort, or you faint</span></li>
    <li><span style="color: #000000;"><strong>High blood pressure (hypertension).</strong> New or worsening high blood pressure has happened in people treated with IMBRUVICA<sup>&reg;</sup>. Your healthcare provider may start you on blood pressure medicine or change current medicines to treat your blood pressure</span></li>
    <li><span style="color: #000000;"><strong>Second primary cancers.</strong> New cancers have happened during treatment with IMBRUVICA<sup>&reg;</sup>, including cancers of the skin or other organs</span></li>
    <li><span style="color: #000000;"><strong>Tumor lysis syndrome (TLS).</strong> TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure and the need for dialysis treatment, abnormal heart rhythm, seizure, and sometimes death. Your healthcare provider may do blood tests to check you for TLS.</span></li>
</ul>
<p><span style="color: #000000;"><strong>The most common side effects of IMBRUVICA<sup style="top: 0px;">&reg;</sup> in adults with B-cell malignancies (MCL, CLL/SLL, WM and MZL)&nbsp; include:</strong></span></p>
<ul class="unordered-list inline-items-3-wide" style="margin-bottom: 0.5em;">
    <li>
    <p>Diarrhea</p>
    </li>
    <li>
    <p>Bruising</p>
    </li>
    <li>
    <p>Muscle and bone pain</p>
    </li>
    <li>
    <p>Tiredness</p>
    </li>
    <li>
    <p>Rash</p>
    </li>
    <li>
    <p>Fever</p>
    </li>
    <li>
    <p>Nausea</p>
    </li>
</ul>
<div class="divider m-5">&nbsp;</div>
<p><span style="color: #000000;"><strong>The most common side effects of IMBRUVICA<strong><sup style="top: 0px;">&reg;</sup></strong> in adults with cGVHD include:</strong></span></p>
<div class="row show-for-medium-up">
<div class="columns small-4 large-4">
<ul class="unordered-list inline-items" style="margin-bottom: 0.5em;">
    <li style="width: 100%;">
    <p>Tiredness</p>
    </li>
    <li style="width: 100%;">
    <p>Bruising</p>
    </li>
    <li style="width: 100%;">
    <p>Diarrhea</p>
    </li>
</ul>
</div>
<div class="columns small-4 large-4">
<ul class="unordered-list inline-items" style="margin-bottom: 0.5em;">
    <li style="width: 100%;">
    <p>Mouth sores (stomatitis)</p>
    </li>
    <li style="width: 100%;">
    <p>Muscle spasms</p>
    </li>
    <li style="width: 100%;">
    <p>Nausea</p>
    </li>
</ul>
</div>
<div class="columns small-4 large-4">
<ul class="unordered-list inline-items" style="margin-bottom: 0.5em;">
    <li style="width: 100%;">
    <p>Pneumonia</p>
    </li>
</ul>
</div>
</div>
<ul class="unordered-list inline-items-3 hide-for-medium-up" style="margin-bottom: 0.5em;">
    <li>
    <p>Tiredness</p>
    </li>
    <li>
    <p>Mouth sores (stomatitis)</p>
    </li>
    <li>
    <p>Pneumonia</p>
    </li>
    <li>
    <p>Bruising</p>
    </li>
    <li>
    <p>Muscle spasms</p>
    </li>
    <li class="hidethis">
    <p>&nbsp;</p>
    </li>
    <li>
    <p>Diarrhea</p>
    </li>
    <li>
    <p>Nausea</p>
    </li>
</ul>
<div class="divider m-5">&nbsp;</div>
<p><span style="color: #000000;"><strong>Diarrhea is a common side effect in people who take IMBRUVICA<sup style="top: 0px;">&reg;</sup>. Drink plenty of fluids during treatment with IMBRUVICA<sup style="top: 0px;">&reg;</sup> to help reduce your risk of losing too much fluid (dehydration) due to diarrhea. Tell your healthcare provider if you have diarrhea that does not go away.</strong></span></p>
<p><span style="color: #000000;">These are not all the possible side effects of IMBRUVICA<sup>&reg;</sup>. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.&nbsp;</span></p>
<p class="title"><strong><span style="color: #00aeef;">General information about the safe and effective use of IMBRUVICA<sup>&reg;</sup></span></strong></p>
<p><span style="color: #000000;">Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use IMBRUVICA<sup>&reg;</sup> for a condition for which it was not prescribed. Do not give IMBRUVICA<sup>&reg;</sup> to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about IMBRUVICA<sup>&reg;</sup> that is written for health professionals.</span></p>
<p><span style="color: #000000;">Please see the full</span> <a href="https://www.imbruvica.com/prescribing-information" target="_blank">Important Product Information</a>.</p>


</div>
                    </div>
                    <div class="large-5 columns">
                        <div class="margin-left-12pct">
                            
<div class='sfContentBlock'><p class="title"><span style="color: #00aeef;">INDICATIONS</span></p>
<p class="title"><strong><span style="color: #00aeef;">What is IMBRUVICA<sup>&reg;</sup> (ibrutinib)?</span></strong></p>
<p><span style="color: #000000;">IMBRUVICA<sup>&reg;</sup> (ibrutinib)&nbsp;is a prescription medicine used to treat adults with:</span></p>
<ul>
    <li><span style="color: #000000;">Mantle cell lymphoma (MCL) who have received at least one prior treatment</span></li>
    <li><span style="color: #000000;">
    Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL)</span></li>
    <li><span style="color: #000000;">Chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL) with 17p deletion</span></li>
    <li><span style="color: #000000;">Waldenstr&ouml;m's macroglobulinemia (WM)</span></li>
    <li><span style="color: #000000;">Marginal zone lymphoma (MZL) who require a medicine by mouth or injection (systemic therapy) and have received a certain type of prior treatment</span></li>
    <li><span style="color: #000000;">Chronic graft versus host disease (cGVHD) after failure of 1 or more lines of systemic therapy&nbsp;</span></li>
</ul>
<p><span style="color: #000000;">It is not known if IMBRUVICA<sup>&reg;</sup> is safe and effective in children.</span></p>


</div>
                        </div>
                    </div>
                </div>
                <div class="row">
                    <div class="large-12 columns">
                        <hr>
                    </div>
                </div>
                <div class="row">
                    <div class="large-12 columns sub-text">
                        
<div class='sfContentBlock'><p>Your use of the information on this site is subject to the terms of the <a class="isi-link" href="legal.html">Legal Notice</a> and new&nbsp;<a class="isi-link" href="http://www.pharmacyclics.com/privacy-policy" target="_blank">Privacy Policy</a> of Pharmacyclics LLC. This site is published by Pharmacyclics LLC which has developed the content in conjunction with Janssen Biotech, Inc. Any information that is collected on this site may be shared between Pharmacyclics LLC and Janssen Biotech, Inc. This information is intended for use by our customers, patients, and healthcare professionals in the United States and Puerto Rico only. Pharmacyclics LLC recognizes that the Internet is a global communication medium; however laws, regulatory requirements, and medical practices vary from country to country.</p>
<p>IMBRUVICA<sup>®</sup> (ibrutinib) is covered by U.S. Patents, which are listed in FDA's Orange Book (available at <a href="https://www.accessdata.fda.gov/scripts/cder/ob/default.cfm" class="show-lso" target="_blank" data-lso-type="1">https://www.accessdata.fda.gov/scripts/cder/ob/default.cfm</a>).</p>


</div>
                    </div>
                </div>
                <div class="row">
                    <div class="large-3 columns sub-text">
                        
<div class='sfContentBlock'><p><nobr>&copy; Pharmacyclics LLC 2019</nobr></p>
<p><nobr>&copy; Janssen Biotech, Inc. 2019</nobr></p>


</div>
                        <p>
                            11/18 PRC-04454</p>
                    </div>
                    <div class="large-9 columns sub-text">
                        <div class="footer-logos">
                            
<div class='sfContentBlock'><a href="http://www.pharmacyclics.com/" target="_blank"><img title="Pharmacyclics Logo" alt="Pharmacyclics, LLC.  An AbbVie Company" src="images/Imbruvica2/logo-pharmacyclics.png"></a>
<a href="http://www.janssen.com/" target="_blank"><img title="Janssen Logo" alt="Janssen Pharmaceutical Companies of Johnson and Johnson" src="images/Imbruvica2/logo-janssen.jpg"></a>


</div>
                        </div>
                    </div>
                </div>
                <div class="row">
                    <div class="large-12 columns large-centered sub-text">
                        
<div class='sfContentBlock'><a class="footer-link" href="index.html">Home</a> | <a href="https://www.imbruvica.com/prescribing-information" class="has-lso footer-link" target="_blank">Prescribing Information</a> | <a href="legal.html#isi">Important Side Effect Information</a> | <a class="footer-link" href="legal.html">Legal Notice</a> | <a class="footer-link" href="http://www.pharmacyclics.com/privacy-policy" target="_blank">Privacy Policy</a>  | <a class="footer-link" href="contact-us.html">Contact Us</a> | <a class="footer-link" href="https://www.imbruvica.com/unsubscribe">Unsubscribe/Update </a>


</div>
                    </div>
                </div>
            </article>
        </div>
    

<script type="text/javascript">
//<![CDATA[
;(function() {
                        function loadHandler() {
                            var hf = $get('ctl09_TSSM');
                            if (!hf._RSSM_init) { hf._RSSM_init = true; hf.value = ''; }
                            hf.value += ';Telerik.Sitefinity.Resources, Version=10.2.6602.0, Culture=neutral, PublicKeyToken=b28c218413bdf563:en:1c3e6627-a90c-4375-b55c-75906376ec60:83fa35c7';
                            Sys.Application.remove_load(loadHandler);
                        };
                        Sys.Application.add_load(loadHandler);
                    })();//]]>
</script>
</form>
    <script>document.write("<script type='text/javascript' src='scripts/Imbruvica2/bundle.min.js%3Fv=&quot;&#32;+&#32;Date.now()&#32;+&#32;&quot;'><\/script>");</script>
    <script>document.write("<script type='text/javascript' src='scripts/Imbruvica2/eventtracking.js%3Fv=&quot;&#32;+&#32;Date.now()&#32;+&#32;&quot;'><\/script>");</script>
    <!--These are polyfills to allow foundation 5 to work on ie8. they MUST remain at the bottom of the index page.-->
    <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.2/html5shiv.js"></script>
    <script src="//s3.amazonaws.com/nwapi/nwmatcher/nwmatcher-1.2.5-min.js"></script>
    <script src="//cdnjs.cloudflare.com/ajax/libs/selectivizr/1.0.2/selectivizr-min.js"></script>
    <script src="//cdnjs.cloudflare.com/ajax/libs/respond.scripts/1.1.0/respond.min.js"></script>
    <![endif]-->
    <!--[if lt IE 9]>
    <script src="/scripts/Imbruvica2/rem.min.js"></script>
    <![endif]-->
     

<!--https://raygun.io/docs/languages#javascript - Start -->
<script type="text/javascript">
     !function (a, b, c, d, e, f, g, h) {
         a.RaygunObject = e, a[e] = a[e] || function () {
             (a[e].o = a[e].o || []).push(arguments)
         }, f = b.createElement(c), g = b.getElementsByTagName(c)[0],
         f.async = 1, f.src = d, g.parentNode.insertBefore(f, g), h = a.onerror, a.onerror = function (b, c, d, f, g) {
             h && h(b, c, d, f, g), g || (g = new Error(b)), a[e].q = a[e].q || [], a[e].q.push({
                 e: g
             })
         }
    }(window, document, 'script', '//cdn.raygun.io/raygun4js/raygun.min.js', 'rg4js');
</script>

<!--https://raygun.io/docs/languages#javascript - End -->

    <script  type="text/javascript">
     rg4js('apiKey', 'uxkHxnVqgYtvlep38k3UzA==');
     rg4js('enableCrashReporting', true);
     rg4js('enablePulse', true);
     rg4js('options', {
         ignoreAjaxAbort: true,
         ignoreAjaxError: true,
         ignore3rdPartyErrors: true
     });
</script>


</body>
</html>
